Valuation of health and nonhealth outcomes from next-generation sequencing: Approaches, challenges, and solutions
<h4>Background</h4> <p>Next-generation sequencing (NGS) technologies have seen variable adoption in the clinic. This is partly due to a lack of clinical and economic studies, with the latter increasingly challenged to examine patient preferences for health and nonhealth outcomes (...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2018
|